Payers strategize to manage opioid use March 29, 2017 By Tracey Walker How managed care organizations manage opioid utilization and some of the limitations to those management strategies was a hot topic at the AMCP Annual Meeting. Top strategies for incorporating PDMP data into physician work flow February 09, 2017 By Aubrey Westgate How can physicians, already struggling to keep up with mounting regulations and larger patient loads, use PDMPs in more effective and efficient ways? How data analytics combats the opioid epidemic Deaths due to opioid abuse have risen sharply—and show no signs of leveling off. Here’s how data analytics can prevent abuse and diversion. Opinion: Hospital formularies can play key role in reducing opioid epidemic December 21, 2016 By T.J. Gan MD Adding non-opioid postsurgical options to hospital formularies should be a top consideration. Study: Use of short-acting opioids decrease, long-acting opioids increase October 07, 2016 By Tracey Walker Executives need to increase awareness in the category and ensure prescribers are aware of CDC guidelines for opioid prescribing and the prescription drug monitoring programs. Five ways you can help fight the opioid epidemic The opioid crisis in the U.S. is a multidimensional problem requiring a multistakeholder solution. Treatment of opioid use disorder As problems with opioid use and abuse in the United States increasingly emerge to create what is being called a public health epidemic, clinicians are facing the great challenge of trying to provide optimal pain management for their patients while being mindful of the potential deleterious effects of the highly addictive opioids. Heroin bill may give boost to providers treating substance abuse September 14, 2015 By Tracey Walker Kentucky Senate Bill 192 may fund substance abuse providers to thwart heroin epidemic. Opioid-dependent patients in ED need more than a treatment referral When addiction treatment was added to the buprenorphine Rx the result was greatly improved outcomes. Actavis gains final FDA approval for generic Subutex February 23, 2015 By Tracey Walker Actavis has received final approval from FDA on its Abbreviated New Drug Application for a generic version of Reckitt Benckiser's Subutex (buprenorphine 2 mg and 8 mg sublingual tablets) indicated for treatment of opioid dependence.